Unitree IPO 2026: $6.2B STAR Market Valuation Ranked Against Figure, 1X, and Tesla Optimus

Unitree priced its Shanghai STAR Market IPO to raise 4.2 billion yuan — about $618 million — at a base valuation near $6.2 billion, making it the first pure-play humanoid robotics company to go public anywhere in the world. That's the short answer. The longer answer is where it ranks against six other companies chasing the same market, and why the IPO landed two days after Washington tightened restrictions on foreign robotics.

I've been tracking the humanoid robotics field since Figure AI's valuation first jumped past $2.6B, and Unitree's listing is the moment the sector gets its first real, market-set price — not a VC term sheet, but a regulator-approved, publicly traded number. That number is smaller than most of the private hype, and that gap is the story.

What Is the Unitree IPO and When Does It Trade?

The Unitree IPO is a Shanghai STAR Market listing in which the Chinese robotics maker is issuing 40.4464 million new shares — 10% of its enlarged share capital — to raise approximately 4.2 billion yuan ($618-622 million). Book-building ran August 5, 2026, public subscription opened August 10, and trading is expected to begin between August 17 and 21, sponsored by CITIC Securities.

Regulatory approval moved unusually fast. The China Securities Regulatory Commission approved Unitree's registration on July 1, 2026, just 104 days after the application was accepted — the fastest review-to-approval turnaround in STAR Market history, and a signal of how much political priority Beijing is placing on getting a homegrown humanoid robotics champion onto public markets before its Western rivals raise another private round.

Unitree IPO Valuation, Ranked Against Every Major Humanoid Robotics Company

Here's how Unitree's ~$6.2 billion IPO valuation ranks against six other humanoid robotics companies, ordered by disclosed or implied valuation as of August 2026:

The Unitree IPO Comparison Table: Valuation, Status, and Backers

Figures are August 2026 estimates blended from Caixin Global, PitchBook, TechCrunch, Forge Global, and Sacra. Valuations for private companies reflect last disclosed priced rounds; SPAC and IPO figures reflect deal or offering terms as announced.

Unitree IPO Financials: Revenue Growth, Margins, and the Slowdown Investors Should Watch

Unitree's revenue grew from roughly 159 million yuan in 2023 to about 393 million yuan in 2024 to 1.708 billion yuan (~$235M) in 2025, a 335% year-over-year jump, at gross margins around 60%. Humanoids overtook the company's original robot-dog business in 2025, making up 52% of revenue for the first time. That's the growth story underpinning the IPO's status as the first public benchmark for humanoid robot valuations, per Forbes.

But the trend line investors should actually watch is the deceleration: first-half 2026 revenue growth slowed to roughly 40% year-over-year, down from 335% the prior year. Growth from a tiny base is easy; growth at $235M in revenue against a 5,500-to-20,000-unit shipment target for 2026 is where the real test starts. A 40% growth rate at a $6.2B valuation implies a very different multiple than a 335% growth rate did a year earlier — and that's before accounting for the fact that Unitree's IPO base valuation already prices in most analysts' optimism about the re-rating.

What the headline misses

The "first humanoid robot IPO" headline undersells two real overhangs. First, the FCC added foreign-produced "advanced robotic devices" to its Covered List on July 28, 2026 — just two days before Unitree formalized its IPO filing — meaning future Unitree products sold in the U.S. will need a specific exception rather than routine market access. Second, the House Select Committee on the CCP has pushed since May 2025 for Unitree to be added to the Commerce Department's Entity List over its sales to Beihang University, a school already on that list, and its reported ties to Chinese police and military buyers. As of this IPO, Unitree is not on the Entity List — but the political pressure is not going away, and any future export restriction would hit precisely the U.S. commercial pipeline Unitree needs to keep growing revenue at anything close to its 2025 pace.

How to Watch (or Access) the Unitree IPO as a US Investor

Direct access is limited: the STAR Market is generally restricted to mainland Chinese accounts, Qualified Foreign Institutional Investors, and Stock Connect-eligible brokerages, none of which cover a typical U.S. retail account. The realistic paths are indirect — China-focused ETFs like KraneShares' STAR Market fund (KSTR) and humanoid robotics fund (KOID), both of which are positioned to add Unitree once it lists — or pre-IPO secondary marketplaces, which have shown indicative pricing but carry the usual liquidity and price-discovery risk of unlisted secondaries. For the broader physical-AI investment thesis this IPO sits inside, see our breakdown of the $1 trillion physical AI opportunity, and for how the China angle fits the national-security debate, our Defense Tech tracker.

The Bottom Line

Unitree's IPO is a genuinely important data point for the entire humanoid robotics sector because it's the first time any of these companies has had to clear a public regulator and public market instead of a boardroom negotiation. A $6.2B base valuation against $235M in decelerating revenue is not a knock on Unitree specifically — it's the market pricing risk that private rounds for Figure, 1X, and Apptronik haven't had to face yet. Whether those companies get priced the same way when they eventually go public is the question this IPO starts answering.